NewYork-Presbyterian, an international leader in transplantation, was among a select group of hospitals nationwide recognized for working to promote enrollment in state organ donor registries through the 2018 National Hospital Organ Donation Campaign.

Weill Cornell Medicine, in collaboration with Columbia University Irving Medical Center and NewYork-Presbyterian, has been awarded a grant of more than $900,000 from the U.S. Department of Defense (DoD) to conduct prostate cancer clinical trials.

Dr. Francis Lee, a leading physician-scientist whose research focuses on anxiety disorders, has been named chairman of the Department of Psychiatry at Weill Cornell Medicine and psychiatrist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.

Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian found that acupuncture was associated with a statistically significant drop in joint pain among women taking aromatase inhibitors, a type of breast cancer treatment.

A multicenter clinical trial has found that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.

September is Ovarian Cancer Awareness Month. Each year, more than 250,000 women across the globe are diagnosed with ovarian cancer, and the cancer causes 140,000 deaths annually. Unfortunately, too often, ovarian cancer is diagnosed too late, as the symptoms are similar to those experienced by a woman experiencing her period or less serious medical conditions.

Magnetic resonance imaging (MRI) may not be the best diagnostic choice universally for all men suspected of having prostate cancer, according to researchers at Weill Cornell Medicine and NewYork-Presbyterian. While recent studies have demonstrated that MRI is more accurate in detecting tumors than other diagnostic procedures, there are barriers that prevent the technique’s widespread use.

Dr. Lisa Newman, an internationally renowned breast surgeon and researcher, has been appointed chief of the Section of Breast Surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Aug. 20. At the NewYork-Presbyterian David H. Koch Center, Dr. Newman will lead multidisciplinary breast oncology programs and provide the finest, most compassionate care to women and men affected by breast cancer.